Pharmakokinetic investigation on the tissue penetration of moxifloxacin within the pericardial space.

Trial Profile

Pharmakokinetic investigation on the tissue penetration of moxifloxacin within the pericardial space.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Moxifloxacin (Primary)
  • Indications Bacterial infections; Pericardial effusion
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 Mar 2012 Actual end date (Mar 2007) added as reported by European Clinical Trials Database record.
    • 31 Mar 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
    • 11 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top